Live News EQUITY FLASH L impact Oct 30, 2026, 11:40 AM UTC HC Wainwright Maintains LENZ Therapeutics at Buy, Cuts Target to $16 HC Wainwright lowered its price target from $38 to $16 while maintaining its Buy rating. LENZ SquawkNews Desk